| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733819 | Journal of Surgical Research | 2017 | 11 Pages |
Abstract
These results indicate that overexpression of ADAMs may contribute to gastric cancer progression and that ADAM-17 is a downstream target of FoxM1. Overall, the present study highlights the potential for FoxM1 and ADAMs as potential therapeutic targets for patients with gastric carcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Wenzheng PhD, Jianxin MD, Qing BA, Ying PhD, Guanzhen PhD,